Company Filing History:
5 out of 39 
2 out of 2 
2 out of 17 Years Active: 2002-2025
Title: Burkhard Gitter: Innovator in Anti-Tumor and Anti-Bacterial Therapies
Introduction
Burkhard Gitter is a prominent inventor based in Jena, Germany, known for his significant contributions to the fields of anti-tumor and anti-bacterial therapies. With a total of 10 patents to his name, Gitter has developed innovative biologically active compounds that have the potential to revolutionize therapeutic applications.
Latest Patents
Gitter's latest patents include the application of boron dipyrromethene derivatives in anti-tumor and anti-bacterial therapy. These compounds serve as photosensitizers for diagnostic and therapeutic applications, particularly in photodynamic therapy (PDT) for cancer and infections. They also have potential uses in treating non-tumorous conditions such as arthritis and inflammatory diseases. Notably, these compounds exhibit toxicity against tumor cells and bacteria even without light, allowing for light-independent treatment options. Additionally, Gitter has developed methods to synthesize complex structures incorporating substituted dipyrromethene units, enhancing the efficacy of these compounds through specific substitutions.
Another significant patent involves the application of dipyrrinato-iridium complexes in similar therapeutic contexts. These compounds also function as photosensitizers and have been designed to treat a range of conditions, including hyperproliferative diseases and infections. The innovative synthesis methods and the introduction of amphiphilic compounds with increased efficacy further highlight Gitter's contributions to the field.
Career Highlights
Throughout his career, Burkhard Gitter has worked with notable companies such as Biolitec Pharma Marketing Ltd and Biolitec Unternehmensbeteiligungs III AG. His work has focused on developing advanced therapeutic solutions that address critical health challenges.
Collaborations
Gitter has collaborated with esteemed colleagues, including Arno Wiehe and Volker Albrecht, to further enhance the impact of his research and innovations.
Conclusion
Burkhard Gitter's work in the development of anti-tumor and anti-bacterial therapies showcases his dedication to advancing medical science. His innovative patents and collaborations reflect a commitment to improving therapeutic options for patients worldwide.